Imagion Biosystems Ltd

IBX

Company Profile

  • Business description

    Imagion Biosystems Ltd operates in the field of non-invasive detection of specific solid tumor cancers by use of magnetic nanoparticles. Its principal continuing activities consisted of Nanotechnology; Biotechnology; Cancer Diagnostics; and Medical Imaging using Magnetic Resonance and Superparamagnetic Relaxometry. The company only operating segment - Research and Development. Its principal business activities consist of nanotechnology, biotechnology, cancer diagnostics, and medical imaging using Superparamagnetic Relaxometry. In addition, the company is engaged in the research and development of its clinical phase lead product which is intended for the detection and staging of metastatic HER2 breast cancer.

  • Contact

    96-100 Albert Road
    Level 4
    South MelbourneVIC3205
    AUS

    T: +61 396927222

    https://www.imagionbiosystems.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Diagnostics & Research

    Fiscal Year End

    31 December 2025

    Employees

Stocks News & Analysis

stocks

Progress in UK expansion for undervalued ASX share

Guidance reaffirmed and UK implementation on track.
stocks

The sectors set to soar on government spending

Governments worldwide love to spend more money, and there are no signs that it will change any time soon.
stocks

Chart of the Week: How private companies are reshaping public markets

Our latest take from the US Manager Research team.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,094.0014.30-0.16%
CAC 408,074.236.700.08%
DAX 4024,049.74100.630.42%
Dow JONES (US)47,311.00225.760.48%
FTSE 1009,777.0862.120.64%
HKSE26,341.76406.351.57%
NASDAQ23,499.80151.160.65%
Nikkei 22550,768.89556.621.11%
NZX 50 Index13,580.4240.56-0.30%
S&P 5006,796.2924.740.37%
S&P/ASX 2008,822.1014.70-0.17%
SSE Composite Index4,003.9634.710.87%

Market Movers